Home › Funds › Citadel Advisors › GRDN
Citadel Advisors position in GRDN
GUARDIAN PHARMACY SVCS INC · Consumer Staples
Latest position (Q2 2026)10.20K sh
Reported value held$427.07K
Portfolio Weight0.00%
First reportedQ3 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 401.13K | $6.74M | New |
| Q2 2025 | 319.25K | $6.80M | New |
| Q2 2025 | 319.25K | $6.80M | New |
| Q3 2025 | 77.66K | $2.04M | Reduce |
| Q1 2026 | 579.12K | $21.81M | New |
| Q2 2026 | 10.20K | $427.07K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GRDN
- Fidelity Management & Research (FMR) 3.24M sh · $135.73M · Q2 2026
- Wellington Management Group 1.73M sh · $72.39M · Q2 2026
- BlackRock Inc 1.58M sh · $65.99M · Q2 2026
- Vanguard Group 1.35M sh · $40.73M · Q4 2025
- Franklin Resources 966.21K sh · $40.46M · Q2 2026
- Geode Capital Management 646.70K sh · $27.08M · Q2 2026
- Morgan Stanley 312.00K sh · $13.06M · Q2 2026
- Northern Trust Corp 211.38K sh · $8.85M · Q2 2026
- Goldman Sachs Group 171.69K sh · $7.19M · Q2 2026
- Lazard Asset Management 169.53K sh · $7.10M · Q2 2026
- Bank of America Corp 163.17K sh · $6.83M · Q2 2026
- Millennium Management 120.61K sh · $5.05M · Q2 2026